Drug Company Halts Late-Stage Trial of Sickle-Cell Disease Drug
... Drug manufacturer icagen announced that it has ended its Phase III clinical trial of its sickle-cell treatment senicapoc, citing lack of effectiveness//, the Raleigh News & Ob...Icagen Terminates Phase III ASSERT Study
...ptions for the development of senicapoc. About icagen Icagen, Inc. is a biopharmaceutical company base...ated scientific and drug development capabilities, icagen has identified multiple drug candidates that modul...ompany is conducting preclinical studies. icagen is also conducting ongoing drug discovery programs...Icagen to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
...nk posted on the investor relations section of the icagen website at www.icagen.com. The webcast will also b...east two weeks following the presentation. About icagen Icagen, Inc. is a biopharmaceutical company base...ated scientific and drug development capabilities, icagen has identified multiple drug candidates that modul...